Advanced wireless technologies and novel approaches to DM therapeutics that once were unimaginable continue to refine diabetes management.
Image ©Sergey Nivens/Shutterstock.com
Afib and T1D: Linked by Cause or Correlation?
A recent study, the first of its kind, reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are interesting gender differences.
Video: When Should Metformin be Omitted?
Guidelines say metformin should be stopped where there is acute kidney injury or risk of renal compromise. Now there is evidence to support those recommendations.
Video: How to Follow an Adrenal Incidentaloma
To image or not to image: A new study validates professional society recommendations on follow-up strategies for adrenal masses.
AACE/ACE Focus on Lipids: 2017 Consensus Guidelines
The AACE/ACE 2017 recommendations on lipid management renew focus on LDL-C targets, and go far lower than any group has ventured to date.
SGLT2 Inhibitor Offers CV, Renal Protection in High-risk Patients
Significant reductions were seen in MACE, renal disease progression in patients with high CV risk taking canagliflozin.
Diet Rich in Omega-6 Fat May Prevent Diabetes
A large international study found people with highest blood levels of linoleic acid were 35% less likely to develop T2DM than those with the lowest levels.
True or False: Diabetes Stats 2017
Can you sort out diabetes facts from fiction? The latest diabetes statistics from the CDC may surprise you.
What Can the “B” Key Do For Your Next Presentation?
This tip and 4 others can help you deliver a message that resonates.
T2D Study Guide, October: SGLT2 Inhibitors, GLP-1 Agonists, CV Outcomes
At-a-glance: SGLT2 inhibitors, GLP-1 agonists, insulin vs insulin, and more—a look at what’s new, what’s next.
T1DM, Pregnancy, and Continuous Glucose Monitoring: Good News
A new open-label randomized controlled trial finds use of CGM in T1DM pregnancies may improve neonatal outcomes.